 Arianne Theiss
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 15 | 2020 | 369 | 4.430 |
Why?
| | Colitis | 11 | 2022 | 226 | 4.140 |
Why?
| | Inflammatory Bowel Diseases | 11 | 2023 | 289 | 3.500 |
Why?
| | Mitochondria | 11 | 2023 | 750 | 2.970 |
Why?
| | Intestinal Mucosa | 17 | 2023 | 528 | 2.610 |
Why?
| | Crohn Disease | 5 | 2023 | 197 | 2.160 |
Why?
| | Paneth Cells | 4 | 2023 | 17 | 2.000 |
Why?
| | STAT3 Transcription Factor | 6 | 2015 | 174 | 1.640 |
Why?
| | Ileitis | 2 | 2023 | 26 | 1.580 |
Why?
| | Benzofurans | 2 | 2020 | 20 | 1.250 |
Why?
| | Colorectal Neoplasms | 3 | 2020 | 617 | 1.240 |
Why?
| | Inflammation | 11 | 2023 | 2499 | 1.120 |
Why?
| | Gastrointestinal Microbiome | 3 | 2023 | 503 | 1.110 |
Why?
| | Caco-2 Cells | 12 | 2018 | 66 | 1.060 |
Why?
| | Colon | 9 | 2021 | 234 | 1.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2021 | 1147 | 1.030 |
Why?
| | Colonic Neoplasms | 4 | 2021 | 222 | 1.000 |
Why?
| | Intestines | 6 | 2023 | 324 | 0.980 |
Why?
| | Epithelial Cells | 6 | 2016 | 961 | 0.950 |
Why?
| | Axin Protein | 2 | 2020 | 17 | 0.910 |
Why?
| | Inflammasomes | 2 | 2021 | 116 | 0.850 |
Why?
| | Tumor Necrosis Factor-alpha | 9 | 2021 | 1137 | 0.850 |
Why?
| | Mitochondrial Membranes | 1 | 2023 | 32 | 0.850 |
Why?
| | Antioxidants | 2 | 2021 | 533 | 0.840 |
Why?
| | Autophagy | 4 | 2023 | 236 | 0.820 |
Why?
| | Mice | 27 | 2023 | 15052 | 0.760 |
Why?
| | Apoptosis | 5 | 2020 | 2377 | 0.740 |
Why?
| | Intestinal Neoplasms | 1 | 2020 | 24 | 0.730 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 145 | 0.700 |
Why?
| | Wnt Proteins | 1 | 2020 | 135 | 0.680 |
Why?
| | Carcinogenesis | 1 | 2020 | 178 | 0.660 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 148 | 0.640 |
Why?
| | beta Catenin | 1 | 2020 | 220 | 0.640 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 4773 | 0.620 |
Why?
| | Animals | 31 | 2023 | 32102 | 0.620 |
Why?
| | Glutarates | 1 | 2018 | 6 | 0.610 |
Why?
| | Cell Nucleus | 1 | 2020 | 553 | 0.600 |
Why?
| | Interleukin-17 | 4 | 2022 | 106 | 0.560 |
Why?
| | Colitis, Ulcerative | 4 | 2021 | 105 | 0.510 |
Why?
| | Dextran Sulfate | 5 | 2018 | 70 | 0.510 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2015 | 449 | 0.490 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2023 | 139 | 0.490 |
Why?
| | Reactive Oxygen Species | 4 | 2023 | 549 | 0.470 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2022 | 11 | 0.460 |
Why?
| | Oxidative Stress | 3 | 2011 | 1093 | 0.450 |
Why?
| | NF-E2 Transcription Factor, p45 Subunit | 1 | 2013 | 3 | 0.440 |
Why?
| | Biological Products | 1 | 2016 | 172 | 0.430 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 348 | 0.400 |
Why?
| | Signal Transduction | 3 | 2023 | 4541 | 0.390 |
Why?
| | Humans | 34 | 2023 | 115587 | 0.380 |
Why?
| | Mice, Transgenic | 6 | 2020 | 1970 | 0.370 |
Why?
| | Mice, Knockout | 7 | 2020 | 2604 | 0.360 |
Why?
| | Nanoparticles | 2 | 2011 | 316 | 0.350 |
Why?
| | alpha Karyopherins | 1 | 2009 | 13 | 0.340 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 83 | 0.330 |
Why?
| | Stress, Physiological | 1 | 2012 | 399 | 0.320 |
Why?
| | Interleukin-6 | 3 | 2007 | 677 | 0.320 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2005 | 281 | 0.320 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 301 | 0.300 |
Why?
| | Biopsy | 3 | 2021 | 1056 | 0.290 |
Why?
| | Collagen | 2 | 2005 | 415 | 0.270 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 23 | 0.260 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 34 | 0.260 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3580 | 0.260 |
Why?
| | Growth Hormone | 1 | 2005 | 99 | 0.250 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 147 | 0.250 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 165 | 0.240 |
Why?
| | Cell Proliferation | 3 | 2020 | 2194 | 0.240 |
Why?
| | Human Growth Hormone | 1 | 2004 | 38 | 0.240 |
Why?
| | Fibroblasts | 2 | 2005 | 839 | 0.230 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1893 | 0.230 |
Why?
| | Butyrates | 1 | 2023 | 53 | 0.220 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2353 | 0.220 |
Why?
| | p21-Activated Kinases | 1 | 2022 | 14 | 0.210 |
Why?
| | Up-Regulation | 2 | 2021 | 820 | 0.200 |
Why?
| | Cell Survival | 2 | 2018 | 1024 | 0.200 |
Why?
| | RNA, Small Interfering | 3 | 2017 | 544 | 0.200 |
Why?
| | Enterocytes | 1 | 2021 | 14 | 0.190 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2021 | 9 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2021 | 12 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 219 | 0.190 |
Why?
| | Gene Silencing | 2 | 2012 | 175 | 0.180 |
Why?
| | Genes, Reporter | 2 | 2013 | 257 | 0.180 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2020 | 3 | 0.180 |
Why?
| | Immunity, Innate | 2 | 2023 | 731 | 0.180 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2020 | 314 | 0.180 |
Why?
| | Epithelium | 1 | 2021 | 297 | 0.180 |
Why?
| | Enterocolitis | 1 | 2020 | 33 | 0.170 |
Why?
| | Organoids | 1 | 2020 | 74 | 0.170 |
Why?
| | Homeostasis | 1 | 2023 | 577 | 0.170 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 72 | 0.170 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 850 | 0.160 |
Why?
| | Interleukin-18 | 1 | 2020 | 222 | 0.160 |
Why?
| | Piperidines | 1 | 2020 | 163 | 0.160 |
Why?
| | Obesity | 1 | 2011 | 2517 | 0.160 |
Why?
| | Immunity, Mucosal | 1 | 2019 | 84 | 0.150 |
Why?
| | Lipid Metabolism | 1 | 2021 | 449 | 0.150 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 356 | 0.150 |
Why?
| | Azoxymethane | 1 | 2018 | 16 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 374 | 0.150 |
Why?
| | Intercellular Adhesion Molecule-3 | 1 | 2017 | 2 | 0.150 |
Why?
| | LIM Domain Proteins | 1 | 2017 | 13 | 0.150 |
Why?
| | RNA, Messenger | 4 | 2017 | 2574 | 0.150 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2017 | 36 | 0.150 |
Why?
| | Curcuma | 1 | 2017 | 1 | 0.150 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2098 | 0.150 |
Why?
| | Oils, Volatile | 1 | 2017 | 6 | 0.150 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 57 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 2 | 2010 | 616 | 0.140 |
Why?
| | Neoplasms | 1 | 2011 | 2118 | 0.140 |
Why?
| | Blotting, Western | 2 | 2013 | 1153 | 0.140 |
Why?
| | Cytokines | 3 | 2017 | 1853 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2023 | 1024 | 0.140 |
Why?
| | Fibrosis | 3 | 2017 | 457 | 0.140 |
Why?
| | DNA Methylation | 1 | 2021 | 498 | 0.140 |
Why?
| | Green Fluorescent Proteins | 2 | 2010 | 377 | 0.140 |
Why?
| | Promoter Regions, Genetic | 1 | 2021 | 1122 | 0.140 |
Why?
| | Glutathione | 2 | 2009 | 303 | 0.140 |
Why?
| | Male | 8 | 2020 | 55949 | 0.140 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 249 | 0.130 |
Why?
| | Myofibroblasts | 1 | 2017 | 116 | 0.130 |
Why?
| | Ubiquitination | 3 | 2022 | 86 | 0.130 |
Why?
| | Oncogene Protein p21(ras) | 1 | 2015 | 16 | 0.130 |
Why?
| | Cells, Cultured | 2 | 2014 | 3914 | 0.130 |
Why?
| | Biological Assay | 1 | 2016 | 114 | 0.130 |
Why?
| | Phosphorylation | 2 | 2022 | 1571 | 0.130 |
Why?
| | Risk | 1 | 2018 | 819 | 0.120 |
Why?
| | Gene Knockdown Techniques | 2 | 2015 | 302 | 0.120 |
Why?
| | Hypoxia | 1 | 2021 | 937 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 388 | 0.120 |
Why?
| | Female | 7 | 2020 | 59913 | 0.120 |
Why?
| | NF-kappa B | 2 | 2010 | 639 | 0.120 |
Why?
| | Interleukin-10 | 2 | 2006 | 299 | 0.120 |
Why?
| | RNA | 2 | 2013 | 819 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2017 | 448 | 0.110 |
Why?
| | Cell Movement | 1 | 2018 | 867 | 0.110 |
Why?
| | Antioxidant Response Elements | 1 | 2013 | 5 | 0.110 |
Why?
| | Protein Binding | 2 | 2020 | 1917 | 0.110 |
Why?
| | Phenotype | 1 | 2021 | 2829 | 0.110 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 31 | 0.110 |
Why?
| | Heme Oxygenase-1 | 1 | 2013 | 53 | 0.110 |
Why?
| | Barrett Esophagus | 1 | 2015 | 147 | 0.110 |
Why?
| | Luciferases | 1 | 2013 | 140 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2016 | 479 | 0.110 |
Why?
| | Peroxidase | 1 | 2013 | 157 | 0.110 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2012 | 55 | 0.100 |
Why?
| | HCT116 Cells | 1 | 2012 | 69 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 317 | 0.100 |
Why?
| | Free Radical Scavengers | 1 | 2012 | 82 | 0.100 |
Why?
| | Intracellular Space | 1 | 2012 | 68 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1048 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 275 | 0.100 |
Why?
| | Polyethyleneimine | 1 | 2011 | 18 | 0.090 |
Why?
| | Th17 Cells | 2 | 2021 | 59 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2012 | 144 | 0.090 |
Why?
| | Disease Progression | 1 | 2018 | 2418 | 0.090 |
Why?
| | DNA | 2 | 2009 | 1356 | 0.090 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 271 | 0.090 |
Why?
| | Time Factors | 3 | 2017 | 6165 | 0.090 |
Why?
| | Protein Carbonylation | 1 | 2009 | 52 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 111 | 0.080 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2009 | 73 | 0.080 |
Why?
| | Protein Transport | 1 | 2009 | 400 | 0.080 |
Why?
| | Gene Expression | 2 | 2020 | 1435 | 0.070 |
Why?
| | Acute Disease | 1 | 2010 | 914 | 0.070 |
Why?
| | Salmonella typhimurium | 1 | 2009 | 161 | 0.070 |
Why?
| | Cell Line | 1 | 2013 | 2651 | 0.070 |
Why?
| | Keratin-8 | 1 | 2007 | 3 | 0.070 |
Why?
| | Transcription Initiation Site | 1 | 2007 | 40 | 0.070 |
Why?
| | Prognosis | 1 | 2014 | 3339 | 0.070 |
Why?
| | Transfection | 1 | 2009 | 866 | 0.070 |
Why?
| | Response Elements | 1 | 2007 | 83 | 0.070 |
Why?
| | Glutathione Transferase | 1 | 2006 | 95 | 0.070 |
Why?
| | Keratins | 1 | 2007 | 176 | 0.070 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2005 | 7 | 0.060 |
Why?
| | Cecum | 1 | 2005 | 32 | 0.060 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2005 | 17 | 0.060 |
Why?
| | Blotting, Northern | 1 | 2005 | 194 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2005 | 60 | 0.060 |
Why?
| | Rats, Inbred Lew | 1 | 2005 | 93 | 0.060 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 56 | 0.060 |
Why?
| | Transcription Factor AP-1 | 1 | 2005 | 82 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2006 | 287 | 0.060 |
Why?
| | Homozygote | 1 | 2005 | 186 | 0.060 |
Why?
| | Granuloma | 1 | 2005 | 85 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2005 | 139 | 0.060 |
Why?
| | Polysaccharides | 1 | 2005 | 80 | 0.060 |
Why?
| | Joints | 1 | 2005 | 84 | 0.060 |
Why?
| | Protein Isoforms | 1 | 2005 | 339 | 0.060 |
Why?
| | Models, Biological | 1 | 2011 | 1646 | 0.060 |
Why?
| | Escherichia coli | 1 | 2007 | 730 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2005 | 340 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2005 | 793 | 0.060 |
Why?
| | Drug Interactions | 1 | 2004 | 347 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2009 | 799 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2000 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2790 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1870 | 0.050 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 37 | 0.050 |
Why?
| | Citrobacter rodentium | 1 | 2020 | 6 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2021 | 235 | 0.040 |
Why?
| | Genotype | 1 | 2005 | 1786 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 111 | 0.040 |
Why?
| | Enterobacteriaceae Infections | 1 | 2020 | 33 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1310 | 0.040 |
Why?
| | Chronic Disease | 1 | 2005 | 1598 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 401 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 194 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 390 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 316 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 431 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 489 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2578 | 0.040 |
Why?
| | Transcription Factors | 1 | 2005 | 1528 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2021 | 726 | 0.040 |
Why?
| | Rats | 1 | 2005 | 5034 | 0.040 |
Why?
| | Curcumin | 1 | 2017 | 29 | 0.040 |
Why?
| | Permeability | 2 | 2007 | 150 | 0.040 |
Why?
| | Collagen Type I | 1 | 2017 | 110 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2017 | 171 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 693 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 133 | 0.030 |
Why?
| | Colonoscopy | 1 | 2017 | 204 | 0.030 |
Why?
| | Actins | 1 | 2017 | 383 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 602 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 1700 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1536 | 0.030 |
Why?
| | Computer Simulation | 1 | 2016 | 881 | 0.020 |
Why?
| | Materials Testing | 1 | 2011 | 356 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4440 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3364 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6417 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2007 | 299 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 304 | 0.020 |
Why?
| | Macrophages | 1 | 2011 | 1284 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 12608 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2007 | 3022 | 0.010 |
Why?
| | Aged | 1 | 2017 | 19251 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 26999 | 0.010 |
Why?
| | Adult | 1 | 2017 | 30718 | 0.010 |
Why?
|
|
Theiss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|